{"doi":"10.1038/261717a0","title":"Antipsychotic drug doses and neuroleptic/dopamine receptors","abstract":null,"journal":"Nature","year":1976,"id":30118,"datarank":19.182985008720863,"base_score":7.3987862754199485,"endowment":7.3987862754199485,"self_citation_contribution":1.1098179413129925,"citation_network_contribution":18.07316706740787,"self_endowment_contribution":1.1098179413129925,"citer_contribution":18.07316706740787,"corpus_percentile":null,"corpus_rank":null,"citation_count":1633,"citer_count":200,"citers_with_citation_signal":200,"citers_with_endowment":200,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":164379,"name":"T. LEE","orcid":null,"position":1,"is_corresponding":false},{"id":164380,"name":"M. CHAU-WONG","orcid":null,"position":2,"is_corresponding":false},{"id":164381,"name":"K. WONG","orcid":null,"position":3,"is_corresponding":false},{"id":164378,"name":"P. SEEMAN","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":7.3987862754199485,"endowment":7.3987862754199485,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"945467","pmcid":null,"openalex_id":"https://openalex.org/W2092416470","authors":[],"funders":[],"total_grants":0,"fwci":41.4711,"citation_percentile":1.0,"influential_citations":28,"citation_trend":[{"year":2012,"count":35},{"year":2013,"count":35},{"year":2014,"count":37},{"year":2015,"count":37},{"year":2016,"count":34},{"year":2017,"count":27},{"year":2018,"count":18},{"year":2019,"count":29},{"year":2020,"count":20},{"year":2021,"count":29},{"year":2022,"count":38},{"year":2023,"count":21},{"year":2024,"count":14},{"year":2025,"count":20},{"year":2026,"count":6}],"oa_status":"closed","license":"http://www.springer.com/tdm","oa_locations":[{"url":"http://www.nature.com/articles/261717a0","host_type":"publisher"},{"url":"http://www.nature.com/articles/261717a0.pdf","host_type":"publisher"},{"url":"https://doi.org/10.1038/261717a0","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/945467","host_type":"repository"}],"fields_of_study":["Schizophrenia research and treatment","Treatment of Major Depression","Receptor Mechanisms and Signaling","Medicine","Animals","Binding, Competitive","Cattle","Caudate Nucleus","Dopamine","Haloperidol","Humans","Rats","Receptors, Drug","Schizophrenia","Tranquilizing Agents"],"mesh_terms":["Animals","Binding, Competitive","Cattle","Caudate Nucleus","Dopamine","Haloperidol","Humans","Receptors, Drug","Schizophrenia","Tranquilizing Agents","Rats"],"keywords":["Haloperidol","Antipsychotic","Antipsychotic drug","Pharmacology","Drug","Antipsychotic Agent","Dopamine","Dopamine receptor","Dopamine receptor D2","Medicine","Receptor","Chemistry","Schizophrenia (object-oriented programming)","Internal medicine","Psychiatry"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-09T01:51:26.223483Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}